Skip to main content
. Author manuscript; available in PMC: 2024 Sep 1.
Published in final edited form as: Neurourol Urodyn. 2024 Apr 16;43(7):1534–1544. doi: 10.1002/nau.25465

Table 1:

Baseline characteristics of long-stay NH residents who underwent PNE and Stage 1 SNM test procedure from 2014 to 2016.

Variable name Total N=1089 (100.0) PNE n=728 (66.9) Stage 1 n=361 (33.2) p
Age in years
 Mean ± SD 77.9 (7.1) 78.0 ± 7.1 77.8 ± 7.2 0.666
 65–74 405 (37.2) 271 (37.2) 134 (37.1) 0.955
 75–84 480 (44.1) 319 (43.2) 161 (44.6)
 ≥85 204 (18.7) 138 (19.0) 66 (18.3)
Sex
 Male 282 (25.9) 201 (27.6) 81 (22.4) 0.067
 Female 807 (74.1) 527 (72.4) 280 (77.6)
Race
 White 1008 (92.6) 672 (92.3) 336 (93.1) 0.857
 Black 53 (4.9) <42 (<5.8) ≥11 (≥3.0)
 Other 28 (2.6) ≥17 (≥2.3) <11 (<3.0)
CCI
 0 128 (11.8) 93 (12.8) 35 (9.7) 0.295
 1 – 3 541 (49.7) 361 (49.6) 180 (49.9)
 ≥4 420 (38.6) 274 (37.6) 146 (40.4)
 Mean ± SD 3.2 ± 2.5 3.2 ± 2.5 3.4 ± 2.5 0.172
CFI
 Not Frail to Prefrail (CFI<0.25) 182 (16.7) 130 (17.9) 52 (14.4) 0.325
 Mildly Frail (0.25 ≤ CFI < 0.35) 575 (52.8) 382 (52.5) 193 (53.5)
 Moderately to Severely Frail (CFI ≥ 0.35) 332 (30.5) 216 (29.7) 116 (32.1)
 Mean ± SD 0.3 ± 0.1 0.3 ± 0.1 0.3 ± 0.1 0.171
ADI National Quartile
 Q1: 1 - < 32 226 (20.8) 151 (20.8) 75 (20.8) 0.686
 Q2: 32 - < 51 252 (23.2) 163 (22.4) 89 (24.7)
 Q3: 51 - < 68 291 (26.8) 192 (26.4) 99 (27.4)
 Q4: ≥ 68 319 (29.3) 221 (30.4) 98 (27.2)
Procedure Year
 2014 341 (31.3) 231 (31.7) 110 (31.5) 0.915
 2015 375 (34.4) 249 (34.2) 126 (34.9)
 2016 373 (34.3) 248 (34.1) 125 (34.6)
Single-stage procedure 86 (7.9) -- 74 (23.8) --

Note: Observations ≤10 suppressed per Centers for Medicare & Medicaid Services (CMS) cell-suppression policy19.

Abbreviations: Area Deprivation Index; CCI, Charlson Comorbidity Index; CFI, Claims-based Frailty Index; CMS, Centers for Medicare & Medicaid Services; NH, nursing home; PNE, percutaneous nerve evaluation.